Only if approved retatrutide ends up on the FDA shortage list, which would trigger the 503A and 503B compounding pathway
Doing so may help your body adapt to the medication and reduce your risk of side effects
Tirzepatide: The Dual Incretin Receptor Agonist Tirzepatide has revolutionized metabolic therapy as the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA
We act as both your rigorous scientific guides and your dedicated coaches throughout this process
Boosted Confidence: Losing weight enables you to exude confidence wherever you go, transforming your whole personality
Some of the smaller ones, they're mixing up the drugs by hand, but, like, gloved hands, because these are trained pharmacists